[1]程显声.进一步提高肺动脉栓塞诊断与处理水平.中华结核和呼吸杂志, 2000, 23:517-518.
[2]Wolfe TR, Allen TL. Syncope晕厥 as an emergency department presentation陈述of pulmonary embolism. J Emerg Med, 1998, 16:27-31.[3] Torbicki A, van Beek EJR, Charbonnier G, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2000, 21: 1301-1336.[4]Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239–245.[5]Dalla-Volta S, Palla A, Santolicandro A, et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment ofacute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520–526.[6] evine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, 98:1473–1479.[7] Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2008, 29: 2276-2315.[8] Konstantinides SV, Torbicki A, Perrier A, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014,35:3033-3073.[9] Chan CM,Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost,2010,8:1509–1514.[10] Righini M, Roy PM, Meyer G, et al. The Simplified Pulmonary EmbolismSeverity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost,2011,9:2115–2117.[11] Aujesky D, Obrosky DS, Stone RA, et al. Derivation andvalidation of a prognostic model for pulmonary embolism[J].Am J Respir Crit Care Med, 2005, 72(8): 1041-1046.[12] Jimenez D, Aujesky D, Moores L, et al. Simplification of thepulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism[J].Archives Internal Med, 2010, 170(15): 1383-1389.[13] Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patientswith intermediate-risk pulmonary embolism[J]. New Engl J Med, 2014, 370(15): 1402-1411.[14] Chen 11, Ren C，Chen 11. 'fhrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism; a meta-analysis of randomized controlled trials[ ,J].Respir Care, 2014， 59(12):1880-1887. D01:10.4187/resocare.03197.[15]Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)[J]. Eur Respir J, 2019,54(3). pii: 1901647. DOI: 10.1183/13993003.01647-2019.
